Reduced postprandial hyperglycemia after subcutaneous injection of a somatostatin-analogue (SMS 201-995) in insulin-dependent diabetes mellitus.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples